Literature DB >> 25368267

Botulinum toxin for salivary disorders in the treatment of head and neck cancer.

Armin Steffen1, Katrin Hasselbacher2, Sabrina Heinrichs2, Barbara Wollenberg2.   

Abstract

BACKGROUND/AIM: During the treatment of head and neck cancer (HNC), salivary problems may impair a patient's healing process. Botulinum toxin (BoNT) is accepted as an effective treatment option for reducing salivary flow. We aimed to describe the features of patients treated with BoNT to determine the effects of BoNT. PATIENTS AND METHODS: Twenty-five patients over a five-year period were retrospectively included. The patients suffered at different stages of oncologic treatment. The cohort primarily had larger primary tumors that required complex oncological treatment.
RESULTS: The condition improved in more than three quarters of the 19 patients with functional hypersalivation. Four of six cases suffering from a salivary fistula demonstrated an obvious reduction in symptoms.
CONCLUSIONS: Injection of BoNT, to temporarily reduce saliva flow, is a safe tool in the treatment of HNC even in situations involving repeated therapy or high dosage. The main clinical side-effect of BoNT is insufficient reduction of the salivary problem. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Botulinum toxin; dysphagia; head neck cancer; hypersalivation; salivary fistula; salivary glands

Mesh:

Substances:

Year:  2014        PMID: 25368267

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Botulinum Toxin Confers Radioprotection in Murine Salivary Glands.

Authors:  Youssef H Zeidan; Nan Xiao; Hongbin Cao; Christina Kong; Quynh-Thu Le; Davud Sirjani
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-29       Impact factor: 7.038

2.  [Ultrasound-guided minimally invasive diagnostics and treatment in the head and neck area].

Authors:  A Bozzato; C Neubert; Y Yeter
Journal:  HNO       Date:  2021-02       Impact factor: 1.284

Review 3.  Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Authors:  Armin Steffen; Wolfgang Jost; Tobias Bäumer; Dirk Beutner; Sabine Degenkolb-Weyers; Martin Groß; Maria Grosheva; Samer Hakim; Kai G Kahl; Rainer Laskawi; Rebekka Lencer; Jan Löhler; Thekla Meyners; Saskia Rohrbach-Volland; Rainer Schönweiler; Sara-Christina Schröder; Sebastian Schröder; Heidrun Schröter-Morasch; Maria Schuster; Susanne Steinlechner; Roland Urban; Orlando Guntinas-Lichius
Journal:  J Neural Transm (Vienna)       Date:  2019-04-10       Impact factor: 3.575

Review 4.  Use of Botulinum Toxin in Orofacial Clinical Practice.

Authors:  Maria-Angeles Serrera-Figallo; Gonzalo Ruiz-de-León-Hernández; Daniel Torres-Lagares; Alejandra Castro-Araya; Omar Torres-Ferrerosa; Esther Hernández-Pacheco; Jose-Luis Gutierrez-Perez
Journal:  Toxins (Basel)       Date:  2020-02-11       Impact factor: 4.546

Review 5.  Non-Surgical Strategies for Assisting Closure of Pharyngocutaneous Fistula after Total Laryngectomy: A Systematic Review of the Literature.

Authors:  Luca Giovanni Locatello; Giuseppe Licci; Giandomenico Maggiore; Oreste Gallo
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

Review 6.  Botulinum Neurotoxins and Cancer-A Review of the Literature.

Authors:  Shivam Om Mittal; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2020-01-05       Impact factor: 4.546

Review 7.  Botulinum toxin in cancer therapy-current perspectives and limitations.

Authors:  Tomasz Grenda; Anna Grenda; Paweł Krawczyk; Krzysztof Kwiatek
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-24       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.